Myriad Genetics (MYGN) Change in Inventory (2011 - 2026)

Myriad Genetics (MYGN) has reported Change in Inventory for 16 consecutive years, with -$2.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Inventory fell 400.0% year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at -$400000.0 (down 107.55% YoY), while the FY2025 annual figure was $3.2 million, down 48.39% from the prior year.
• Change in Inventory eased to -$2.7 million in Q1 2026 per MYGN's latest filing, from -$900000.0 in the prior quarter.
• Across five years, Change in Inventory topped out at $4.3 million in Q3 2022 and bottomed at -$3.2 million in Q4 2023.
• Historically, Change in Inventory has averaged $712500.0 across 5 years, with a median of $750000.0 in 2023.
• Annual changes were most pronounced in 2023 — Change in Inventory jumped 750.0% — and 2026, when it slumped 400.0%.
• Myriad Genetics' Change in Inventory stood at -$1.5 million in 2022, then sank by 113.33% to -$3.2 million in 2023, then jumped by 140.62% to $1.3 million in 2024, then plunged by 169.23% to -$900000.0 in 2025, then slumped by 200.0% to -$2.7 million in 2026.
• Business Quant data shows MYGN's Change in Inventory at -$2.7 million in Q1 2026, -$900000.0 in Q4 2025, and $2.9 million in Q3 2025.